343 related articles for article (PubMed ID: 27380892)
1. Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses.
Flipse J; Diosa-Toro MA; Hoornweg TE; van de Pol DP; Urcuqui-Inchima S; Smit JM
Sci Rep; 2016 Jul; 6():29201. PubMed ID: 27380892
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.
Huang X; Yue Y; Li D; Zhao Y; Qiu L; Chen J; Pan Y; Xi J; Wang X; Sun Q; Li Q
Sci Rep; 2016 Feb; 6():22303. PubMed ID: 26923481
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
[TBL] [Abstract][Full Text] [Related]
5. How antibodies alter the cell entry pathway of dengue virus particles in macrophages.
Ayala-Nunez NV; Hoornweg TE; van de Pol DP; Sjollema KA; Flipse J; van der Schaar HM; Smit JM
Sci Rep; 2016 Jul; 6():28768. PubMed ID: 27385443
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent and dependent infection of human myeloid cells with dengue virus is inhibited by carrageenan.
Piccini LE; Carro AC; Quintana VM; Damonte EB
Virus Res; 2020 Dec; 290():198150. PubMed ID: 32866533
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
[TBL] [Abstract][Full Text] [Related]
8. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
9. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
10. Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes.
Diwaker D; Mishra KP; Ganju L; Singh SB
Arch Virol; 2014 Aug; 159(8):1975-86. PubMed ID: 24590566
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
12. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
[TBL] [Abstract][Full Text] [Related]
13. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
[TBL] [Abstract][Full Text] [Related]
14. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.
Nicholson CO; Costin JM; Rowe DK; Lin L; Jenwitheesuk E; Samudrala R; Isern S; Michael SF
Antiviral Res; 2011 Jan; 89(1):71-4. PubMed ID: 21093488
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
Smith SA; Nivarthi UK; de Alwis R; Kose N; Sapparapu G; Bombardi R; Kahle KM; Pfaff JM; Lieberman S; Doranz BJ; de Silva AM; Crowe JE
J Virol; 2016 Jan; 90(2):780-9. PubMed ID: 26512092
[TBL] [Abstract][Full Text] [Related]
16. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.
Boonnak K; Dambach KM; Donofrio GC; Tassaneetrithep B; Marovich MA
J Virol; 2011 Feb; 85(4):1671-83. PubMed ID: 21123382
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators.
Kamaladasa A; Gomes L; Jeewandara C; Shyamali NL; Ogg GS; Malavige GN
Antiviral Res; 2016 Sep; 133():183-90. PubMed ID: 27476044
[TBL] [Abstract][Full Text] [Related]
18. Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection.
Fang CY; Chen SJ; Wu HN; Ping YH; Lin CY; Shiuan D; Chen CL; Lee YR; Huang KJ
Viruses; 2015 Sep; 7(9):4894-910. PubMed ID: 26378567
[TBL] [Abstract][Full Text] [Related]
19. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage.
Martínez Gómez JM; Ong LC; Lam JH; Binte Aman SA; Libau EA; Lee PX; St John AL; Alonso S
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004536. PubMed ID: 27007501
[TBL] [Abstract][Full Text] [Related]
20. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes.
Kou Z; Lim JY; Beltramello M; Quinn M; Chen H; Liu S; Martinez-Sobrido L; Diamond MS; Schlesinger JJ; de Silva A; Sallusto F; Jin X
Virology; 2011 Feb; 410(1):240-7. PubMed ID: 21131015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
